BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24126958)

  • 21. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
    Patel A; Waheed U; Brett SJ
    Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
    [No Abstract]   [Full Text] [Related]  

  • 22. Is the literature inconclusive about the harm from HES? Yes.
    Ertmer C; Annane D; Van Der Linden P
    Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxyethyl starch solutions and patient harm.
    Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K
    Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012
    [No Abstract]   [Full Text] [Related]  

  • 24. Is the literature inconclusive about the harm of HES? We are not sure.
    Schetz M; Shaw AD; Vincent JL
    Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
    [No Abstract]   [Full Text] [Related]  

  • 25. Starch solutions in Australia: the empire strikes back.
    Bellomo R
    Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
    [No Abstract]   [Full Text] [Related]  

  • 26. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
    Biancofiore G; Vaglio S; Liumbruno GM
    Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
    [No Abstract]   [Full Text] [Related]  

  • 27. [Not Available].
    Hahn R
    Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
    [No Abstract]   [Full Text] [Related]  

  • 28. EMA recommendation to suspend HES is hazardous.
    Annane D; Fuchs-Buder T; Zoellner C; Kaukonen M; Scheeren TWL
    Lancet; 2018 Feb; 391(10122):736-738. PubMed ID: 29449011
    [No Abstract]   [Full Text] [Related]  

  • 29. Hydroxyethyl starches should not be used in critically ill patients.
    Johnston M; Clarke L
    J R Army Med Corps; 2008 Sep; 154(3):214. PubMed ID: 19205089
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydroxyethyl starch: Statement of the Presidents of DGAI and the BDA and the President of the DAAF].
    Werner C; Geldner G; Koch T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):437. PubMed ID: 23929160
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluids in acute respiratory distress syndrome: pros and cons.
    Silva PL; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):104-12. PubMed ID: 24345852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risks of hydroxyethyl starch 130/0.4 in cardiac surgery.
    Haynes GR
    J Pharm Pract; 2014 Feb; 27(1):17-8. PubMed ID: 24436438
    [No Abstract]   [Full Text] [Related]  

  • 33. "Colloid twice daily" is not fluid resuscitation! Inappropriate inclusion of clinical trials in meta-analyses may distract from gaps in evidence.
    Kranke P; Roewer N; Muellenbach RM
    Intensive Care Med; 2013 Aug; 39(8):1503. PubMed ID: 23736139
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydroxyethyl starch: here today, gone tomorrow.
    Nolan JP; Mythen MG
    Br J Anaesth; 2013 Sep; 111(3):321-4. PubMed ID: 23946354
    [No Abstract]   [Full Text] [Related]  

  • 35. The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.
    Laake JH; Tønnessen TI; Chew MS; Lipcsey M; Hjelmqvist H; Wilkman E; Pettilä V; Hoffmann-Petersen J; Møller MH;
    Acta Anaesthesiol Scand; 2018 Jul; 62(6):874-875. PubMed ID: 29658984
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hydroxyethylstarches and renal failure: to keep the reason is a necessity].
    Godet G; Girard C; Guidet B; Ichai C; Lehot JJ; Leone M; Martin C; Muller L; Orliaguet G; Payen JF; Sztark F
    Ann Fr Anesth Reanim; 2013 Sep; 32(9):535-8. PubMed ID: 23972629
    [No Abstract]   [Full Text] [Related]  

  • 37. Time to assess alternatives to hydroxyethyl starch to use instead of 0.9% saline in fluid replacement.
    Cruickshanks M; Drummond GB; Paterson-Brown S; Powell AG
    BMJ; 2013 Jul; 347():f4651. PubMed ID: 23900815
    [No Abstract]   [Full Text] [Related]  

  • 38. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery.
    Kancir AS
    Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxyethyl starch-induced postoperative bleeding in cardiac surgery patients: more trials needed?
    Wilkes MM; Navickis RJ
    Chest; 2004 Jul; 126(1):311-2; author reply 312. PubMed ID: 15249479
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of hydroxyethyl starch in critically ill patients.
    Bugedo G; Romero C
    Crit Care; 2013 Oct; 17(5):455. PubMed ID: 24088504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.